GENE ONLINE|News &
Opinion
Blog

2025-12-01|

Study Identifies Role of Transcription Factors in siRNA Production and Epigenetic Gene Regulation in Plants

by GOAI
Share To

A recent study has identified a direct link between transcription factors and the production of small interfering RNAs (siRNAs) in plants, revealing an intricate mechanism that connects gene regulation at the transcriptional level with epigenetic control. Researchers found that transcription factors play a pivotal role in orchestrating siRNA production, which is essential for regulating gene expression and maintaining genome stability.

The findings highlight how transcription factors influence siRNA biogenesis, bridging two critical processes in molecular biology. Transcription factors are proteins that bind to specific DNA sequences to regulate gene activity, while siRNAs are small RNA molecules involved in silencing genes through RNA interference mechanisms. This study demonstrates that transcription factors not only regulate genes directly but also initiate the production of siRNAs, which contribute to epigenetic modifications and gene silencing. The discovery provides new insights into plant molecular biology and expands understanding of how genetic and epigenetic processes interact.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: December 1, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
LATEST
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
Janux Therapeutics Shares Halve Despite Positive Phase I Trial Results for Solid Tumor Therapy
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
2025-12-04
2025 Healthcare+ Expo Taiwan
Taipei, Taiwan
Scroll to Top